Adjuvia Therapeutics Closes $8 Million Series Seed Financing to Advance Novel Mitochondrial Disease Therapy into the Clinic

[#item_full_content]SAN FRANCISCO–(BUSINESS WIRE)– #AdjuviaTherapeutics–Adjuvia Therapeutics raises $8 million to advance ATI-105, a novel mitochondrial disease therapy, into Phase 1 clinical trials.

Leave a Reply

Your email address will not be published. Required fields are marked *